Published online Nov 19, 2026. doi: 10.5498/wjp.124210
Revised: July 23, 2026
Accepted: August 31, 2026
Published online: November 19, 2026
Processing time: 142 Days and 16.2 Hours
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with onset in early childhood. Conventional behavioral interventions are limited by poor adherence and variable efficacy. Animal-assisted intervention (AAI) creates a low-stress therapeutic environment through positive human-animal interaction and has become an important adjunctive approach for ASD. This review summarizes the clinical evidence, underlying mechanisms, and current limitations of AAI. Clinical evidence indicates that dog-assisted and equine-assisted interventions can improve core symptoms and common comorbidities. However, treatment effects are highly heterogeneous, effect sizes vary widely, several high-quality studies have reported no significant benefit, and the overall level of evidence remains low. Mechanistically, AAI may act through multiple pathways involving neurobiological regulation, physiological and immune modulation, psychological and behavioral processes, and sensorimotor integration. To date, only hypothalamic-pituitary-adrenal axis regulation, autonomic nervous system modulation, and social brain network remodeling have gained preliminary direct support. Synaptic plasticity, immune-inflammatory regulation, and mitochondrial metabolism remain largely hypothetical. Optimal mechanisms may differ across ASD sub
Core Tip: This review evaluates clinical evidence and mechanisms of animal-assisted intervention (AAI) for autism spectrum disorder. Clinically, dog- or equine-assisted interventions improve symptoms and comorbidities, but efficacy is highly heterogeneous with variable effect sizes, and several high-quality studies demonstrate no significant benefit, indicating low-quality evidence. Mechanistically, AAI regulates hypothalamic-pituitary-adrenal axis, oxytocin, social brain networks, autonomic function, and sensorimotor integration. However, direct evidence is limited to neuroendocrine responses, heart rate variability, and electroencephalographic changes; synaptic plasticity, immune regulation, and mitochondrial metabolism remain theoretical. Optimal mechanisms differ by subgroup, highlighting stratification by age, cognition, and sensory characteristics. Methodologically, animal stress is a confounder affecting interaction quality. Future trials are supposed to include animal stress as a covariate and establish stratified frameworks for standardized, evidence-based AAI practice.